The Orlucent® system has been

tested in over 1000 patients.

Orlucent is conducting global clinical trials to identify transition thresholds in early tissue remodeling, and to document the clinical impact of point of care, non-invasive biological information in the management of moles.

For more information or if you are interested in participating in clinical trials or product evaluations contact us at [email protected].

©2023 Orlucent, Inc.  Los Gatos, California, USA     Contact:  [email protected]

LBL0246 A

 Currently in clinical trials.  Research Use Only.

©2023 Orlucent, Inc.  Los Gatos, California, USA

Contact:  [email protected]  

 Currently in clinical trials.

Research Use Only.